David García-González, María Romero-Elías, Alejandro Álvarez-Bustos, Silvia Rosado-García, Antonio J Sánchez-López, Blanca Cantos, Constanza Maximiano, Miriam Méndez, Marta Méndez-Otero, Héctor Cebolla, Jesús García-Foncillas, Ana Ruiz-Casado
{"title":"Cancer-Related Fatigue and Circulating Biomarkers in Breast Cancer Survivors.","authors":"David García-González, María Romero-Elías, Alejandro Álvarez-Bustos, Silvia Rosado-García, Antonio J Sánchez-López, Blanca Cantos, Constanza Maximiano, Miriam Méndez, Marta Méndez-Otero, Héctor Cebolla, Jesús García-Foncillas, Ana Ruiz-Casado","doi":"10.1177/10998004231215777","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Cancer-related fatigue (CRF) is the most common and disruptive symptom experienced by cancer survivors and because of its frequency and severity is especially worrisome in breast cancer survivors (BCS). Despite a great deal of research, the mechanisms underlying CRF have not been determined. The present study aims to describe associations between CRF in BCS and different blood biomarkers.</p><p><strong>Methods: </strong>A descriptive and cross-sectional study was conducted. A set of biomarkers assessing inflammation were measured in BCS: C-reactive protein (CRP), neutrophil-lymphocyte ratio (NLR), IL-1β, IL-6, IL-8, IL-10, tumor necrosis factor (TNF); HPA axis dysfunction (cortisol), autonomic dysfunction (noradrenaline); oxidative stress (8-OH deoxyguanosine); insulin resistance markers (insulin, IGF-I, IGFBP3) and sexual hormones (estrogens, progesterone, testosterone).</p><p><strong>Results: </strong>NLR (<i>p =</i> .00) and cortisol (<i>p =</i> .02) were positive and negatively associated with CRF, respectively. The rest of the blood markers were not associated with CRF.</p><p><strong>Conclusion: </strong>Our results increase the evidence on pathophysiological mechanisms driving CRF in BCS. However, longitudinal studies are needed to explore the role of these factors as potential causal mechanisms.</p>","PeriodicalId":93901,"journal":{"name":"Biological research for nursing","volume":" ","pages":"270-278"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological research for nursing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/10998004231215777","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/11/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Cancer-related fatigue (CRF) is the most common and disruptive symptom experienced by cancer survivors and because of its frequency and severity is especially worrisome in breast cancer survivors (BCS). Despite a great deal of research, the mechanisms underlying CRF have not been determined. The present study aims to describe associations between CRF in BCS and different blood biomarkers.
Methods: A descriptive and cross-sectional study was conducted. A set of biomarkers assessing inflammation were measured in BCS: C-reactive protein (CRP), neutrophil-lymphocyte ratio (NLR), IL-1β, IL-6, IL-8, IL-10, tumor necrosis factor (TNF); HPA axis dysfunction (cortisol), autonomic dysfunction (noradrenaline); oxidative stress (8-OH deoxyguanosine); insulin resistance markers (insulin, IGF-I, IGFBP3) and sexual hormones (estrogens, progesterone, testosterone).
Results: NLR (p = .00) and cortisol (p = .02) were positive and negatively associated with CRF, respectively. The rest of the blood markers were not associated with CRF.
Conclusion: Our results increase the evidence on pathophysiological mechanisms driving CRF in BCS. However, longitudinal studies are needed to explore the role of these factors as potential causal mechanisms.